# Live From WCLC 2025: Sunday Highlights

An episode of [Lung Cancer Considered](https://invisiblenetwork.ai/podcast/1655997630), 7 Sep 2025, 24 min.

Audio: https://feeds.soundcloud.com/stream/2166413586-lungcancerconsidered-live-from-wclc-2025-sunday-highlights.mp3

In this special WCLC 2025 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu discuss daily highlights from the conference. Dr. David Planchard discusses the data that we all were waiting for the FLAURA-2 overall survival. Dr. Alexander Drilon shares results from the ARROS-1 study including efficacy results and safety data for zidesamtinib, a new ROS1 inhibitor that could change the landscape in the ROS1 space.

Shows are listed from Apple Podcasts' charts and directory, and Podcast Index where it is used. Every show and episode belongs to its publisher and plays from the publisher's own feed; this site hosts none of them.